Lantheus Considering Potential $7 Billion Sale Following Curium's Takeover Offer
Lantheus Holdings is evaluating a potential sale after receiving a takeover offer from private equity-backed Curium Pharma, valued at approximately $7 billion. The deal discussions could lead to an agreement in the coming weeks, though no final decision has been made.